Otolaryngology · Chula Vista, CA
NPI
1881190767
Since 2018
Specialty
Otolaryngology
Code 207Y00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
321 E St
Chula Vista, CA, 91910
Phone (619) 934-3260
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
118 services
Medicare patients, 2024
37
Average age 73
Drug cost, 2024
$74K
1,179 prescriptions
Company payments, 2025
$79.05
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laila Rasul was code 99204 (office e&m - new), 19 times for 19 patients. In total Laila Rasul billed 118 services in 22 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-12-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99204 Office E&M - New | Office | 19 | 19 | $133.67 | $2,540 |
| 31231 Nasal/Sinus Endoscopy | Office | 17 | 16 | $160.12 | $2,722 |
| 99214 Office E&M - Established | Office | 16 | 15 | $103.64 | $1,658 |
| 31575 Other Organ Systems | Office | 11 | 11 | $88.35 | $972 |
| 69210 Other Organ Systems | Office | 11 | 11 | $28.26 | $311 |
Medicare prescription drug claims, 2024
In 2024, the drug Laila Rasul prescribed most often to Medicare patients was Fluticasone Propionate, with 432 prescriptions and refills. In total Laila Rasul wrote 1,179 Medicare prescriptions that cost $74K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 432 | 664 | 170 | $5,598 |
| Azelastine Hcl Generic | 191 | 316 | 72 | $4,389 |
| Prednisolone Acetate Generic | 132 | 138 | 71 | $7,030 |
| Omeprazole Generic | 81 | 174 | 46 | $1,050 |
| Ipratropium Bromide Generic | 49 | 68 | 18 | $1,270 |
| Xhance Fluticasone Propionate | 43 | 43 | Under 11 | $49K |
| Prednisone Generic | 27 | 27 | 25 | $71.42 |
| Methylprednisolone Generic | 22 | 22 | 18 | $97.24 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 19 | 19 | 17 | $122 |
| Montelukast Sodium Generic | 19 | 57 | Under 11 | $426 |
| Ibuprofen Generic | 19 | 19 | 16 | $89.44 |
| Dexamethasone Sodium Phosphate Generic | 15 | 15 | 12 | $866 |
| Clotrimazole Generic | 14 | 14 | Under 11 | $388 |
| Mometasone Furoate Generic | 13 | 19 | Under 11 | $1,016 |
| Ofloxacin Generic | 11 | 11 | Under 11 | $493 |
Brand drugs: 183 claims; generic drugs: 996 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laila Rasul $79.05 ($79.05 in general payments such as food, travel and fees) from 2 companies. The largest payer was Aerin Medical Inc. with $61.49.
| Company | Payments | Amount |
|---|---|---|
| Aerin Medical Inc. | 2 | $61.49 |
| Optinose US, Inc. | 1 | $17.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.